GENEVA, May 12 -- JANUX THERAPEUTICS, INC. (10955 Vista Sorrento Parkway, Suite 200San Diego, California 92130) filed a patent application (PCT/US2025/053010) for "ANTIBODIES FOR TARGETING PSMA AND USES THEREOF" on Oct 29, 2025. With publication no. WO/2026/096559, the details related to the patent application was published on May 07, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CAMPBELL, David (10955 Vista Sorrento Parkway, Suite 200San Diego, California 92130), DIRAIMONDO, Thomas R. (10955 Vista Sorrento Parkway, Suite 200San Diego, California 92130)

Abstract: Disclosed herein are isol...